NCT00232141 - Study of Pregabalin Versus Placebo in the Treatment of Nerve Pain Associated With HIV Neuropathy | Biotech Hunter

Enrollment

302

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions

HIV InfectionsPeripheral Neuropathy

Interventions

DRUG

pregabalin

75mg BID (can be titrated up to 150mg BID on day 4 based on individual response and up to 300mg BID at the end of week 1, visit 3 and end of week 2, visit 4)

DRUG

Placebo

Trial Locations (44)

10018

Pfizer Investigational Site, New York

10021

Pfizer Investigational Site, New York

10029

Pfizer Investigational Site, New York

14642

Pfizer Investigational Site, Rochester

19104

Pfizer Investigational Site, Philadelphia

30309

Pfizer Investigational Site, Atlanta

32960

Pfizer Investigational Site, Vero Beach

33133

Pfizer Investigational Site, Miami

33407

Pfizer Investigational Site, West Palm Beach

34695

Pfizer Investigational Site, Safety Harbor

35294

Pfizer Investigational Site, Birmingham

53226

Pfizer Investigational Site, Milwaukee

60611

Pfizer Investigational Site, Chicago

60612

Pfizer Investigational Site, Chicago

63110

Pfizer Investigational Site, St Louis

72207

Pfizer Investigational Site, Little Rock

75204

Pfizer Investigational Site, Dallas

75208

Pfizer Investigational Site, Dallas

75219

Pfizer Investigational Site, Dallas

75605

Pfizer Investigational Site, Longview

78229

Pfizer Investigational Site, San Antonio

78705

Pfizer Investigational Site, Austin

80262

Pfizer Investigational Site, Denver

85023

Pfizer Investigational Site, Phoenix

90025

Pfizer Investigational Site, Los Angeles

90028

Pfizer Investigational Site, Los Angeles

90069

Pfizer Investigational Site, West Hollywood

92103

Pfizer Investigational Site, San Diego

94117

Pfizer Investigational Site, San Francisco

94301

Pfizer Investigational Site, Stanford

96816

Pfizer Investigational Site, Honolulu

97209

Pfizer Investigational Site, Portland

98104

Pfizer Investigational Site, Seattle

95817-1460

Pfizer Investigational Site, Sacramento

32504-5719

Pfizer Investigational Site, Pensacola

21287-7609

Pfizer Investigational Site, Baltimore

02215

Pfizer Investigational Site, Boston

01107

Pfizer Investigational Site, Springfield

63110-1010

Pfizer Investigational Site, St Louis

75208-4234

Pfizer Investigational Site, Dallas

75390-9036

Pfizer Investigational Site, Dallas

00716

Pfizer Investigational Site, Ponce

00909-1711

Pfizer Investigational Site, San Juan

00936-0000

Pfizer Investigational Site, San Juan

All Listed Sponsors

lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY